Filing Details
- Accession Number:
- 0001651844-18-000022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-13 09:39:54
- Reporting Period:
- 2018-11-09
- Accepted Time:
- 2018-11-13 09:39:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-11-09 | 327 | $2.05 | 3,210,240 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-11-09 | 100 | $2.06 | 3,210,340 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-11-09 | 5,573 | $2.06 | 3,215,913 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-11-09 | 6,300 | $2.12 | 3,222,213 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-11-09 | 700 | $2.14 | 3,222,913 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |